(Q42515032)

1 November 2017

A simple method to measure stride length as an index of nigrostriatal dysfunction in mice (English)

1 reference

1 November 2017

Pierre O Fernagut

1

1 reference

1 November 2017

Elsa Diguet

series ordinal

2

1 reference

1 November 2017

Bertrand Labattu

series ordinal

3

1 reference

1 November 2017

François Tison

series ordinal

4

1 reference

1 November 2017

1 January 2002

1 reference

Journal of Neuroscience Methods

1 November 2017

1 reference

1 November 2017

113

1 reference

1 November 2017

2

1 reference

1 November 2017

123-130

1 reference

Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Experimental models of Parkinson's disease: from the static to the dynamic

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Quantitative analysis of gait in Parkinson patients: increased variability of stride length

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Gait analysis in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Role of neostriatum and nucleus accumbens in stepping induced by apomorphine and dexamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Neuromotor alterations and cerebellar deficits in aged arylsulfatase A-deficient transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Gait initiation by patients with lower-half parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

The MPTP-treated mouse as a model of parkinsonism: how good is it?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

The gait abnormality of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

The pathogenesis of gait hypokinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Abnormalities in the stride length-cadence relation in parkinsonian gait.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Motor somatotopy in the striatum of rat: manipulation, biting and gait

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Depletion and recovery of neuronal monoamine storage in rats of different ages treated with reserpine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

The pathophysiology of parkinsonism in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

Pharmacokinetics and effects of haloperidol in the isolated mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900485-X

7 January 2021

10.1016/S0165-0270(01)00485-X

Identifiers

DOI

1 reference

1 November 2017

1 reference